Australia markets closed

Janux Therapeutics, Inc. (JANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
41.47-1.75 (-4.05%)
At close: 04:00PM EDT
40.68 -0.79 (-1.90%)
After hours: 05:36PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
19,205
51,426
35,582
7,813
-
Other short-term investments
324,823
275,590
339,383
0
-
Total cash
344,028
327,016
374,965
7,813
-
Net receivables
-
-
0
8,000
0
Other current assets
5,213
5,423
2,054
249
-
Total current assets
349,241
332,439
377,019
16,062
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
30,755
30,337
1,728
176
-
Accumulated depreciation
-2,914
-972
-131
-21
-
Net property, plant and equipment
27,841
29,365
1,597
155
-
Other long-term assets
3,325
2,206
1,208
-
-
Total non-current assets
31,166
31,571
2,805
155
-
Total assets
380,407
364,010
379,824
16,217
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
-
-
-
4,000
Accounts payable
2,424
2,159
2,458
428
-
Accrued liabilities
4,084
5,508
2,608
465
-
Deferred revenues
1,705
5,406
5,163
1,950
-
Other current liabilities
-
169
1,203
52
-
Total current liabilities
13,033
16,507
12,797
3,181
-
Non-current liabilities
Deferred revenues
0
2,221
700
6,050
-
Total non-current liabilities
23,025
26,763
700
27,674
-
Total liabilities
36,058
43,270
13,497
30,855
-
Stockholders' equity
Common stock
46
42
41
1
-
Retained earnings
-168,763
-110,470
-47,411
-14,739
-
Accumulated other comprehensive income
665
-1,535
-270
0
-
Total stockholders' equity
344,349
320,740
366,327
-14,638
-
Total liabilities and stockholders' equity
380,407
364,010
379,824
16,217
-